1. P766: CLINICAL OUTCOMES IN PATIENTS WITH HIGHER-RISK MYELODYSPLASTIC SYNDROMES RECEIVING HYPOMETHYLATING AGENTS: A LARGE POPULATION-BASED ANALYSIS. (23rd June 2022) Authors: Zeidan, A. M.; Mearns, E. S.; Ng, C.; Shah, A.; Lamarre, N.; Yellow-Duke, A.; Alrawashdh, N.; Yang, B.; Cheng, W.; Bui, C. N.; Svensson, A. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 661 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗